Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-249279
Filing Date
2025-10-24
Accepted
2025-10-24 06:03:04
Documents
13
Period of Report
2025-10-24

Document Format Files

Seq Description Document Type Size
1 6-K d21546d6k.htm 6-K 10199
2 EX-99.1 d21546dex991.htm EX-99.1 15164
3 EX-99.2 d21546dex992.htm EX-99.2 20805
4 EX-99.3 d21546dex993.htm EX-99.3 23530
5 EX-99.4 d21546dex994.htm EX-99.4 52283
6 EX-99.5 d21546dex995.htm EX-99.5 24057
7 GRAPHIC g21546g1022083203832.jpg GRAPHIC 2580
8 GRAPHIC g21546g1022083222190.jpg GRAPHIC 2601
9 GRAPHIC g21546g1022083240598.jpg GRAPHIC 2891
10 GRAPHIC g21546g1022083241070.jpg GRAPHIC 2415
11 GRAPHIC g21546g1022083307813.jpg GRAPHIC 2601
12 GRAPHIC g21546g1022083325863.jpg GRAPHIC 2580
13 GRAPHIC g21546g77a40.jpg GRAPHIC 4876
  Complete submission text file 0001193125-25-249279.txt   176508
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251414189
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)